Altchem Ltd 4
4 · Osmotica Pharmaceuticals plc · Filed Jan 15, 2020
Insider Transaction Report
Form 4
Altchem Ltd
10% Owner
Transactions
- Purchase
Ordinary Shares
2020-01-13$5.00/sh+1,250,000$6,250,000→ 22,485,297 total
Holdings
- 1,182,243(indirect: By LLC)
Ordinary Shares
Footnotes (2)
- [F1]The acquisition of Ordinary Shares reported on this Form 4 (the "Acquired Shares") was made pursuant to an underwritten public offering of Ordinary Shares by Osmotica Pharmaceuticals plc (the "Issuer"). In connection with such offering, the underwriters reimbursed the Issuer for any discounts and commissions payable by the Issuer with respect to the Acquired Shares (the "Discount"). The Issuer in turn paid a fee equal to the amount of the Discount to Altchem Limited totaling $406,250 (the "Fee"), or $0.325 per share. The $5.00 per share price does not reflect payment of the Fee to Altchem Limited.
- [F2]Represents shares of the Issuer held by Orbit Co-Invest A-1 LLC. Altchem Limited is the sole manager of Orbit Co-Invest A-1 LLC. As a result, Altchem Limited may be deemed to share voting and investment power with respect to the shares held by Orbit Co-Invest A-1 LLC. Altchem Limited disclaims beneficial ownership of such shares, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.